Latest news
LSTA: Q2 net loss narrowed, merger terminated, workforce cut 72%, and strategic review underway - TradingViewTradingView · Thu, 06 Aug 2026 20:06:24 GMTRx Rundown: Supernus Pharmaceuticals, TCGX, Sandoz and more - Medical Marketing and MediaMedical Marketing and Media · Thu, 06 Aug 2026 13:33:55 GMTLisata Therapeutics Announces Major Workforce Reduction and Retrenchment - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 10:42:00 GMTLisata Therapeutics Cuts 72% of Workforce and Sues Kuva Labs Following Failed Merger - geneonline.comgeneonline.com · Wed, 05 Aug 2026 02:07:22 GMTLisata axes 72% of workforce following failed merger with Kuva - BioSpaceBioSpace · Tue, 04 Aug 2026 18:43:39 GMTLisata Therapeutics (LSTA) Pursues Legal Action After Merger Ter - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:59:40 GMTLisata Therapeutics Files Suit Against Kuva Labs, Reviews Strategic Alternatives and Cuts Workforce to Preserve Cash - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:15:00 GMTLisata Therapeutics moves forward with legal action following Kuva merger termination - Proactive InvestorsProactive Investors · Tue, 04 Aug 2026 08:48:00 GMT